The National Institutes of Health (NIH) is
sponsoring a Consensus Development Conference on Adjuvant Therapy for
Breast Cancer, to be held in Bethesda, Maryland, on November 1-3, 2000.
The conference will focus on new data on chemotherapy, hormonal
therapy, and other aspects of treatment that have emerged over the
past decade since the last consensus conference, and will culminate
in the formulation of recommendations for clinical practice.
During the conference, a panel of experts (from outside of the NIH)
will hear presentations from leading researchers and then consider
questions on specific topics, such as the selection of chemotherapy,
radiation therapy, and hormonal therapy. The agenda will also include
the clinical use of prognostic markers and quality-of-life issues.
Both node-negative and node-positive breast cancers will be discussed.
Health professionals, researchers, patient advocates, and other
members of the public may register to attend by sending an e-mail to email@example.com
or by going to the NIH web site for consensus conferences found at http://odp.od.nih.gov/consensus.
Additional information is available by calling (301) 592-3320.